These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 27743861

  • 1. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X, Yuan Z, Liu R, Hassan HM, Yang H, Sun R, Zhang L, Jiang Z.
    Toxicol Appl Pharmacol; 2016 Nov 15; 311():12-25. PubMed ID: 27743861
    [Abstract] [Full Text] [Related]

  • 2. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
    Li X, Liu R, Luo L, Yu L, Chen X, Sun L, Wang T, Hylemon PB, Zhou H, Jiang Z, Zhang L.
    Arch Toxicol; 2017 Jan 15; 91(1):481-494. PubMed ID: 27090119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K, Kim YM, Kim YW, Kim SG.
    Drug Metab Dispos; 2011 Aug 15; 39(8):1451-9. PubMed ID: 21596890
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, Dent P.
    Hepatology; 2002 Apr 15; 35(4):779-89. PubMed ID: 11915023
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F, Xi L, Duan Y, Qin H, Wei M, Wu Y, Li B, Zhou Y, Wu X.
    Eur J Pharm Sci; 2018 Oct 15; 123():404-415. PubMed ID: 30077711
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat.
    Henríquez-Hernández LA, Flores-Morales A, Santana-Farré R, Axelson M, Nilsson P, Norstedt G, Fernández-Pérez L.
    J Pharmacol Exp Ther; 2007 Feb 15; 320(2):695-705. PubMed ID: 17108234
    [Abstract] [Full Text] [Related]

  • 11. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q, Chen X, Wang C, Liu Q, Sun H, Sun P, Huo X, Liu Z, Yao J, Liu K.
    Pharm Res; 2015 Nov 15; 32(11):3688-98. PubMed ID: 26040663
    [Abstract] [Full Text] [Related]

  • 12. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.
    Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Peláez F, Wright SD, Cui J.
    J Biol Chem; 2004 Mar 05; 279(10):8856-61. PubMed ID: 14684751
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of cilostazol via the HNF1α/FXR signalling pathway and anti-apoptotic mechanisms in a rat model of estrogen-induced intrahepatic cholestasis.
    Hassan M, Salem MB, Hammam OA, ElZallat M.
    Sci Rep; 2024 Oct 01; 14(1):22751. PubMed ID: 39349582
    [Abstract] [Full Text] [Related]

  • 14. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T, Zheng R, Xu L, Zhou M, Wang X, Guo Q, Ji H, Li L.
    Toxicol Appl Pharmacol; 2020 Dec 01; 408():115248. PubMed ID: 32976922
    [Abstract] [Full Text] [Related]

  • 15. Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression.
    Kim MJ, Kang YJ, Kwon M, Choi YA, Choi MK, Chi HY, Yoo HH, Shim CK, Song IS.
    Int J Mol Sci; 2018 Apr 09; 19(4):. PubMed ID: 29642532
    [Abstract] [Full Text] [Related]

  • 16. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G, Pasini P, Roda A, Spampinato S.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1755-63. PubMed ID: 15935148
    [Abstract] [Full Text] [Related]

  • 17. [Effects of farnesoid X receptor ligand on the metabolism of bile acids in rats with estrogen-induced intrahepatic cholestasis of pregnancy].
    Zou SL, Liu J, Lan Y, Cheng H, Gan XL.
    Zhonghua Gan Zang Bing Za Zhi; 2008 May 15; 16(5):383-6. PubMed ID: 18510855
    [Abstract] [Full Text] [Related]

  • 18. Ursodeoxycholic acid and 18β-glycyrrhetinic acid alleviate ethinylestradiol-induced cholestasis via downregulating RORγt and CXCR3 signaling pathway in iNKT cells.
    Li X, Liang X, Gu X, Zou M, Cao W, Liu C, Wang X.
    Toxicol In Vitro; 2024 Apr 15; 96():105782. PubMed ID: 38244730
    [Abstract] [Full Text] [Related]

  • 19. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
    Barone M, Francavilla A, Polimeno L, Ierardi E, Romanelli D, Berloco P, Di Leo A, Panella C.
    Hepatology; 1996 May 15; 23(5):1159-66. PubMed ID: 8621149
    [Abstract] [Full Text] [Related]

  • 20. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
    Katona M, Hegyi P, Kui B, Balla Z, Rakonczay Z, Rázga Z, Tiszlavicz L, Maléth J, Venglovecz V.
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb 01; 310(3):G193-204. PubMed ID: 26608189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.